ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

ADTX Aditxt Inc

1,464
0,024 (1,67%)
Zuletzt aktualisiert: 15:51:26
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Aditxt Inc ADTX NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,024 1,67% 1,464 15:51:26
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
1,44 1,44 1,47 1,44
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
14.6.202422:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12.6.202422:35EDGAR2Form 8-K - Current report
07.6.202423:12EDGAR2Form PRER14A - Preliminary Proxy Soliciting materials
29.5.202422:33EDGAR2Form PRE 14A - Other preliminary proxy statements
28.5.202412:08EDGAR2Form 8-K - Current report
22.5.202422:24EDGAR2Form 8-K - Current report
20.5.202422:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15.5.202412:50PRNUSEvofem Biosciences Announces Financial Results for the First..
13.5.202422:15EDGAR2Form 8-K - Current report
08.5.202422:15EDGAR2Form 8-K - Current report
07.5.202422:15EDGAR2Form 8-K - Current report
03.5.202420:14BWCORRECTING and REPLACING Aditxt Announces Pricing of $4.2..
03.5.202415:00BWAditxt Announces Pricing of $4.2 Million Private Placement..
02.4.202414:30BWAditxt Signs a Definitive Agreement to Acquire Appili..
27.3.202413:36PRNUSEvofem Reports $18.2 million of Phexxi Net Product Sales in..
11.3.202421:51EDGAR2Form 8-K - Current report
07.3.202413:54PRNUSFor Women Using GLP-1 Receptor Agonists who take Oral Birth..
04.3.202423:27EDGAR2Form 425 - Prospectuses and communications, business..
04.3.202423:24EDGAR2Form 8-K - Current report
01.3.202422:01EDGAR2Form 8-K - Current report
29.2.202422:01EDGAR2Form 8-K - Current report
22.2.202423:21EDGAR2Form 8-K/A - Current report: [Amend]
21.2.202422:30EDGAR2Form 8-K - Current report
16.2.202422:30EDGAR2Form 8-K - Current report
15.2.202422:30EDGAR2Form 8-K - Current report
14.2.202415:26EDGAR2Form S-1/A - General form for registration of securities..
09.2.202422:31EDGAR2Form 8-K - Current report
06.2.202422:30EDGAR2Form 8-K - Current report
02.2.202422:28EDGAR2Form 425 - Prospectuses and communications, business..
02.2.202422:26EDGAR2Form 8-K - Current report
01.2.202414:00PRNUSEvofem Biosciences Announces Strong Preliminary Results,..
30.1.202423:28EDGAR2Form 8-K - Current report
30.1.202422:30EDGAR2Form 8-K - Current report
30.1.202414:30BWAditxt, Inc. Acquires Proprietary Electroencephalography..
23.1.202422:18EDGAR2Form D - Notice of Exempt Offering of Securities
19.1.202422:15EDGAR2Form 8-K - Current report
18.1.202422:30EDGAR2Form S-1 - General form for registration of securities under..
09.1.202423:19EDGAR2Form 425 - Prospectuses and communications, business..
09.1.202423:16EDGAR2Form 8-K - Current report
08.1.202414:30BWAditxt, Inc.’s Subsidiary Pearsanta, Inc. Acquires MDNA Life..
05.1.202422:30EDGAR2Form 8-K - Current report
05.1.202414:45EDGAR2Form 8-K - Current report
05.1.202414:30BWAditxt Announces Closing of $6.0 Million Private Placement..
02.1.202414:45EDGAR2Form 8-K - Current report
02.1.202414:30BWAditxt, Inc. Regains Compliance with Nasdaq Stockholders’..
29.12.202323:07BWAditxt Announces $6 Million Private Placement Priced..
26.12.202323:26EDGAR2Form 8-K - Current report
22.12.202323:00EDGAR2Form 8-K - Current report
22.12.202322:30EDGAR2Form 8-K - Current report
21.12.202322:30EDGAR2Form 8-K - Current report

Kürzlich von Ihnen besucht